Differential diagnostic value of two dimensional multi-breath-hold susceptibility weighted imaging for hepatocellular carcinoma and hepatic hemangioma

doi:10.3969/j.issn.1006-7795.2013.03.007

Abstract

Abstract:

Objective To compare the efficacy of susceptibility weighted imaging (SWI) in detection and differentiation of hepatocellular carcinoma and hemangioma. Methods The data of 41 patients with 51 hepatocellular carcinoma lesions and 13 patients with 23 hemangioma lesions during Jan to Feb,2012 were selected.All patients underwent MR including SWI in the study. Two radiologists interpreted SWI images and measured the signal intensity (SI) of the lesions,adjacent liver parenchyma SI and standard deviation (Sd), while the signal noise ratio (SNR) and the contrast noise ratio (CNR) were calculated. The detecting rates of the lesions and the mean SNR and CNR were compared between the two diseases. Results There were no significant difference in the detecting rate of hemangioma and hepatocellular carcinoma by SWI. The SNR and CNR of hemangioma were higher than those of hepatocellular carcinoma on DWI (P<0.05), and there was a significant difference between the two diseases as for the SNR and CNR. Conclusion SWI is valuable in diagnosis and differential diagnosis of hepatocellular carcinoma and hemangioma.

Key words: susceptibility weighted imaging, hepatocellular carcinoma, hemangioma

CLC Number:

R 445.2

LI Yunfang, LI Hongjun, ZHAO Dawei. Differential diagnostic value of two dimensional multi-breath-hold susceptibility weighted imaging for hepatocellular carcinoma and hepatic hemangioma[J]. Journal of Capital Medical University, 2013, 34(3): 358-363.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2013.03.007

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2013/V34/I3/358

References

[1] Haacke E M, Mittal S, Wu Z, et al. Susceptibility-weighted imaging: technical aspects and clinical applications. part 1[J]. AJNR Am J Neuroradiol,2009,30(1):19-30.

[2] Mittal S, Wu Z, Neelavalli J, et al. Susceptibility-weighted imaging: technical aspects and clinical applications. part 2[J].AJNR Am J Neuroradiol,2009,30(2):232-252.

[3] 李秋云, 肖恩华, 李华兵, 等. 磁敏感成像技术在肝脏局灶性病变的初步应用[J]. 中国临床医学影像杂志,2011,22(1): 100.

[4] Dai Y, Zeng M, Li R, et al. Improving detection of siderotic nodules in cirrhotic liver with a multi-breath-hold susceptibility-weighted imaging technique[J]. J Magn Reson Imaging,2011,34(2):318-325.

[5] Reichenbach J R, Haacke E M. High-resolution BOLD venographic imaging: a window into brain function[J]. NMR Biomed,2001,14(7－8):453-467.

[6] Tsui Y K, Tsai F Y, Hasso A N, et al. Susceptibility-weighted imaging for differential diagnosis of cerebral vascular pathology: a pictorial review[J]. J Neurol Sci,2009,287(1－2):7-16.

[7] Di Bisceglie A M, Axiotis C A, Hoofnagle J H, et al. Measurements of iron status in patients with chronic hepatitis[J]. Gastroenterology, 1992,102(6):2108-2113.

[8] Xidakis C, Kolios G, Valatas V, et al. Effect of octreotide on apoptosis-related proteins in rat Kupffer cells: a possible anti-tumour mechanism[J]. Anticancer Res, 2004,24(2B):833-841.

[9] Naito M, Hasegawa G, Ebe Y, et al. Differentiation and function of Kupffer cells[J]. Med Electron Microsc, 2004,37(1):16-28.

[10] Clària J, Titos E. Kupffer cell[J]. Gastroenterol Hepatol, 2004,27(4):264-273.

[11] Chen G G, Lau W Y, Lai P B. Activation of Kupffer cells inhibits tumor growth in a murine model system[J]. Int J Cancer, 2002,99(5):713-720.

[12] 张秋霞, 赵晖, 于楠, 等. 硝石矾石散对免疫性肝损伤小鼠肝脏病理的影响[J]. 首都医科大学学报, 2007,28(2):200-202.

[13] Rose M L, Rivera C A, Bradford B U, et al. Kupffer cell oxidant production in central to the mechanism of peroxisome proliferators[J]. Carcinogenesis, 1999,20(1):27-33.

[14] Tsujimoto T, Kuriyama S, Yamazaki M, et al. Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers[J]. Int J Oncol, 2001,18(1):41-47.

[15] Toth C A, Thomas P. Liver endocytosis and Kupffer cells [J]. Hepatology, 1992,16(1):255-266.

[16] Terasaki S, Kaneko S, Kobayashi K, et al. Histological features predicting malignant transformation of nonmalignant hepatocellular nodules:a prospective study[J]. Gastroenterology, 1998,115(5):1216-1222.

[17] Hultcrantz R. Studies on the rat liver following iron overload. A morphometrical investigation of parenchymal and Kupffer cells[J]. Acta Pathol Microbiol Immunol Scand A, 1983,91(2):125-132.

[18] Lee K H, Liapi E, Vossen J A, et al. Distribution of iron oxide containing embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy[J]. J Vasc Interv Radiol,2008,19(10):1490-1496.

[19] Lv W, Yan F, Zeng M, et al. Value of abdominal susceptibility-weighted magnetic resonance imaging for quantitative assessment of hepatic iron deposition in patients with chronic hepatitis B: comparison with serum iron markers[J]. J Int Med Res,2012,40(3):1005-1015.

[20] Barnes S R, Haacke E M. Susceptibility-weighted imaging: clinical angiographic applications[J]. Magn Reson Imaging Clin N Am,2009,17(1):47-61.

[21] Fujima N, Kudo K, Terae S, et al. Spinal arteriovenous malformation:evaluation of change in venous oxygenation with susceptibility-weighted MR imaging after treatment[J]. Radiology,2010,254(3):891-899.

[22] Saini J, Thomas B, Bodhey N K, et al. Susceptibility-weighted imaging in cranial dural arteriovenous fistulas[J]. AJNR Am J Neuroradiol,2009,30(1):E6.

[23] Paley M R, Mergo P J, Torres G M, et al. Characterization of focal hepatic lesions with ferum oxides-enhenced T2-weighted MR imaging[J]. AJR Am J Roentgenol,2000,175(1):159-163.

[24] Cooper A D, Campeau N G, Meissner I. Susceptibility-weighted imaging in familial cerebral cavernous malformations[J]. Neurology,2008,71(5):382.